Ignite Creation Date:
2025-12-18 @ 9:58 AM
Ignite Modification Date:
2025-12-18 @ 9:58 AM
Study NCT ID:
NCT07081022
Status:
None
Last Update Posted:
2025-08-21 00:00:00
First Post:
2025-07-15 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
Sponsor:
None
Organization:
Study Overview
Official Title:
JS203 Combination Regimens in B-Cell Non-Hodgkin's Lymphoma
Status:
None
Status Verified Date:
2025-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the preliminary efficacy of JS203 combined with standard regimens in patients with B-cell Non-Hodgkin's lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: